Pregnancy outcome following first trimester exposure to sumatriptan

S. Shuhaiber, A. Pastuszak, B. Schick, D. Matsui, G. Spivey, J. Brochu, Gideon Koren

Research output: Contribution to journalArticlepeer-review

76 Scopus citations


We prospectively compared pregnancy outcome after exposure to sumatriptan with that of disease-matched controls and nonteratogen controls. There were no differences in the rates of live births, spontaneous abortions, therapeutic abortions, or major birth defects among the three groups. This first prospective report suggests that the use of sumatriptan during organogenesis is not associated with an apparent increased risk of major birth defects.

Original languageEnglish
Pages (from-to)581-583
Number of pages3
Issue number2
StatePublished - Aug 1998
Externally publishedYes


Dive into the research topics of 'Pregnancy outcome following first trimester exposure to sumatriptan'. Together they form a unique fingerprint.

Cite this